# Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

> clinical trial · VERIFIED · 2026-06-15

Status: RECRUITING · Sponsor: Sanofi · Condition: Chronic Obstructive Pulmonary Disease

- Company: Sanofi
- Sector: respiratory
- Primary source: https://clinicaltrials.gov/study/NCT07190222

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.